Related by context. All words. (Click for frequent words.) 86 Index CDAI 83 CDAI score 81 CDAI 80 Index CDAI score 79 NIH CPSI 75 Psoriasis Area 75 DAS# CRP 75 Disease Activity 74 DAS# [002] 74 Ocular Surface Disease 74 NIHSS 74 Scale EDSS 73 Montgomery Asberg Depression 73 HAQ DI 73 YMRS 73 IBDQ 72 HDRS 72 serum HBV DNA 72 HOMA IR 72 Severity Index PASI 71 serum urate 71 SELENA SLEDAI 71 PASI scores 71 Brief Psychiatric 71 nasal symptom 71 Score IPSS 71 Rating Scale MADRS 71 Expanded Disability Status 71 ADAS cog 71 Scale EDSS score 71 Alzheimer Disease Assessment 71 Score DAS# 71 Ishak fibrosis score 70 serologically active patients 70 CCyR 70 MADRS score 70 PSADT 70 Montgomery Åsberg Depression 70 PANSS total 70 RECIST Response Evaluation Criteria 70 Severity MSCS score 70 HBeAg seroconversion 70 alanine aminotransferase ALT 69 ACR# ACR# 69 glycosylated hemoglobin HbA1c 69 HAM D# 69 ACR Pedi 69 Y BOCS 69 albumin excretion rate 69 ACR# response 69 oxycodone CR 69 Primary endpoints 69 ADAS Cog 69 Solid Tumors criteria 69 platelet reactivity 69 Brief Pain 69 SELENA SLEDAI score 69 Inventory BPI 68 liver histology 68 serum aminotransferase levels 68 lumbar spine BMD 68 alanine aminotransferase 68 corticosteroid dose 68 International Prostate Symptom 68 Visual Analogue Scale VAS 68 MMSE score 68 glycated hemoglobin levels 68 ADCS CGIC 68 mTSS 68 endoscopic remission 68 Score DAS 68 elevated ALT 68 lopinavir r arm 68 hemoglobin A1c HbA1c 68 leukocyte count 68 HAMD 68 baseline HbA1c 68 aspartate aminotransferase AST 68 CR nPR 68 Ejection Fraction 67 mL/min/#.# m 2 67 serum urate levels 67 detectable HCV RNA 67 subscore 67 EDSS score 67 IRLS score 67 HbA 1c levels 67 DLQI 67 QTcF 67 plus methotrexate 67 ACR# responses 67 plasma HCV RNA 67 serum phosphate 67 Hb A1C 67 hours postdose 67 UPDRS motor 67 WOMAC 67 Response Evaluation Criteria 67 DAS# remission 67 IPSS 67 WOMAC pain 67 confirmed CCyR 67 serum HCV RNA 67 Visual Analog Scale 67 Health Assessment Questionnaire 67 annualized relapse 67 hemoglobin A1c levels 67 hip BMD 67 aspartate aminotransferase 67 pain subscale 67 Pharmacokinetic parameters 67 mg BID dose 67 cEVR 67 timepoints 67 bronchial hyperresponsiveness 67 Skin sterol 67 urinary albumin 67 nonfatal MI 66 Unified Parkinson Disease 66 symptomatic VTE 66 PANSS 66 Scale cognitive subscale 66 lactate dehydrogenase LDH 66 CK MB 66 HBeAg negative patients 66 DAS# scores 66 UPDRS 66 morphometric vertebral fractures 66 fasting plasma glucose FPG 66 achieved ACR# 66 estimated glomerular filtration 66 symptom severity 66 demonstrated clinically meaningful 66 Kaplan Meier estimates 66 mcg QD 66 PSA nadir 66 SUVmax 66 certolizumab 66 CIMZIA TM certolizumab pegol 66 mRS 66 undetectable HCV RNA 66 glycated hemoglobin HbA1c 66 QIDS SR 66 OSDI 66 BPH Symptom Score 66 secondary efficacy endpoint 66 MADRS 66 apnea hypopnea 66 ADHD RS 66 aminotransferases 66 BMI z 66 NIHSS score 66 Knodell necroinflammatory score 66 log# copies mL 66 Viral load 65 apnea hypopnea index 65 #.#/#.# mmHg [001] 65 complete cytogenetic response 65 EDSS scores 65 binary restenosis 65 Fibromyalgia Impact Questionnaire 65 ADHD Rating Scale 65 posttreatment 65 APACHE II 65 HBeAg 65 Negative Syndrome 65 biochemical relapse 65 aminotransferase ALT 65 XIENCE V PROMUS Stent 65 serum cortisol 65 tapentadol ER 65 NYHA functional class 65 glomerular filtration 65 complete cytogenetic 65 MoxDuo TM IR 65 MCyR 65 spirometric 65 inflammatory lesions 65 serum PSA 65 serum phosphorous 65 serum testosterone 65 relapsed MM 65 SGOT 65 HbA 1c 65 calculated creatinine clearance 65 CIMZIA TM 65 clinically meaningful improvement 65 Virologic 65 Secondary endpoints included 65 FluCAM arm 65 mmHg diastolic 65 Female Sexual Function 65 incontinence episodes 65 sustained virological response 65 atheroma volume 65 HER2 expression 65 8mg/kg 65 #mg/day [001] 65 mucosal healing 65 plasma creatinine 65 mineral density BMD 65 ertapenem 65 ARB telmisartan 65 SGRQ 65 A1c levels 65 creatinine clearance 65 cTnT levels 65 Score TOS 65 glomerular filtration rate 65 lumbar spine bone 65 Global Impression CGI 65 pCR 65 postintervention 65 -#.# log# 65 Endothelial function 65 TNSS 65 bortezomib refractory 65 severe exacerbations 65 Insulin sensitivity 64 depressive symptom 64 CIMZIA ™ 64 serum parathyroid hormone 64 4mg/kg 64 Fasting blood glucose 64 visceral adiposity 64 periprocedural 64 sustained virologic response 64 tipranavir r 64 -#.# mg dL [001] 64 mg TID 64 postprocedure 64 Secondary endpoints 64 achieving PASI 64 undetectable HBV DNA 64 SGPT 64 HbA1c levels 64 nondiabetic patients 64 virologic response 64 Secondary endpoints include 64 subscores 64 antibody titer 64 fasting insulin 64 nadroparin 64 mg/m2 dose 64 troponin T 64 timepoint 64 activated partial thromboplastin 64 urine albumin 64 serum calcium levels 64 ALT elevation 64 scores TNSS 64 postoperative complication 64 Secondary efficacy endpoints 64 sUA 64 microbiological eradication 64 fructosamine 64 PREZISTA r arm 64 serum calcium 64 urinary N telopeptide 64 recurrent venous thromboembolism 64 adjunctive placebo 64 % Confidence Interval 64 Operative mortality 64 ACR# [002] 64 specific antigen PSA 64 intima media thickness 64 ng dL 64 aminotransferase levels 64 transaminase elevations 64 hematological parameters 64 radiographic progression 64 fluticasone salmeterol 64 achieved PASI 64 lymphocyte count 64 virologic response EVR 64 achieved statistical significance 64 UPDRS scores 64 Solid Tumors RECIST 64 NIS LL 64 ipsilateral stroke 64 Erectile Function IIEF 64 HbA1C levels 64 p = .# [001] 64 #.#ng/ml 64 haematologic 64 creatinine ratio 64 nicardipine 64 mg QD 64 moderate renal impairment 64 -#.# mg dL [002] 64 HSCT 64 postoperative mortality 64 mcg BID 64 β blockers 64 CHADS2 64 exhaled NO 64 Capacity FVC 64 Dyspnea 64 plasma cortisol 64 alteplase 64 prospectively stratified 64 response CCyR 64 pulmonary capillary wedge 64 fasting plasma glucose 64 virological response 63 ejection fractions 63 GERD symptom 63 Scale PANSS 63 Rating Scale UPDRS 63 postdose 63 SCr 63 CI -#.# 63 nonfatal myocardial infarction 63 CNS LS 63 nonfasting triglyceride levels 63 baseline LDH 63 definite stent thrombosis 63 serum phosphorus 63 serum estradiol 63 KRAS mutations occur 63 serum creatinine levels 63 clodronate 63 Symptom severity 63 hematologic parameters 63 EBMT criteria 63 posttransplant 63 HBV DNA levels 63 baseline A1C 63 OGTT 63 WOMAC TM 63 perioperative mortality 63 Mean Symptom Complex 63 neutrophil counts 63 titrated glipizide 63 evaluable subjects 63 preintervention 63 Platelet counts 63 carotid IMT 63 plasma renin activity 63 BILAG 63 salivary cortisol 63 lactate dehydrogenase 63 glycated hemoglobin 63 sUA levels 63 gadolinium enhancing lesions 63 seropositive patients 63 baseline FEV 63 Rating Scale BPRS 63 colorectal adenoma 63 ug kg 63 Cardiorespiratory fitness 63 Hemoglobin A1c 63 extrapyramidal symptoms 63 Proteinuria 63 salivary flow 63 NMIBC 63 salmeterol fluticasone propionate 63 composite endpoint 63 AST ALT 63 Flu Cy 63 HBV DNA 63 ALT elevations 63 APTIVUS r 63 SVR# 63 ACTEMRA TM 63 preoperatively 63 ALT normalization 63 #mg/day [002] 63 myocardial reperfusion 63 ATACAND 63 methacholine challenge 63 tipranavir ritonavir 63 Hypotension 63 serum magnesium 63 carotid stenosis 63 dose pravastatin 63 AUA Symptom Score 63 serum prostate 63 PSQI 63 mg kg dose 63 tolterodine ER 63 serum triglycerides 63 Non inferiority 63 reinfarction 63 albumin excretion 63 baseline PASI 63 CrCl 63 REYATAZ r arm 63 p = .# [002] 63 estimated GFR 63 HCV RNA 63 RECIST criteria 63 coronary stenosis 63 imatinib therapy 62 μmol L 62 adalimumab Humira 62 eNO 62 HIV RNA 62 ARCOXIA 62 SSRI SNRI 62 WOMAC scores 62 spontaneous bowel movements 62 Pain Intensity 62 leucopenia 62 -#.# log# copies mL 62 % CI #.#-#.# [007] 62 CRp 62 pulmonary exacerbations 62 Kaplan Meier analysis 62 aPTT 62 receiving VICTRELIS 62 erythrocyte sedimentation rate 62 serum potassium 62 intraobserver 62 interferon beta therapy 62 progression TTP 62 HBeAg positive patients 62 subscale scores 62 preoperative PSA 62 cytogenetic response 62 IELT 62 tumor progression TTP 62 receiving golimumab 62 Thrombolysis 62 macroalbuminuria 62 prespecified 62 hypophosphatemia 62 desvenlafaxine succinate 62 HbA1C 62 thromboembolic complications 62 leukocyte counts 62 transaminases 62 ischemia driven 62 confidence intervals CIs 62 methotrexate monotherapy 62 left ventricular diastolic 62 serum BDNF 62 adenoma recurrence 62 CR CRu 62 chlorambucil 62 blood Phe levels 62 NPH insulin 62 intact parathyroid hormone 62 advanced adenoma 62 TEAEs 62 State Examination MMSE 62 echocardiographic parameters 62 steroid dexamethasone 62 octreotide LAR 62 mm Hg systolic 62 cinacalcet 62 Folfox 62 serum IGF 62 asymptomatic carotid stenosis 62 BARACLUDE ® 62 TMC# r 62 neutropaenia 62 ULORIC 62 Natalizumab 62 mmol l 62 multivariate Cox 62 fasting plasma 62 Doxil ® 62 angiographic outcomes 62 QRS duration 62 MAGE A3 ASCI 62 EXJADE 62 clinically meaningful reductions 62 ARIXTRA 62 STRIDE PD 62 tolvaptan 62 PCWP 62 #.#mg/dL 62 incidence ≥ 62 #q# deletion syndrome 62 ADCS ADL 62 angiographic restenosis 62 Visual acuity 62 foveal thickness 62 hydroxyvitamin D levels 62 placebo dexamethasone 62 highly emetogenic 62 abdominal pain abdominal discomfort 62 HAM D# scores 62 Glomerular filtration rate 62 interobserver 62 hepatorenal syndrome 62 BENICAR HCT 62 FOLFOX6 62 prospectively defined 62 primidone 62 p = NS 62 anemia hemoglobin 62 erection hardness 62 Glasgow Coma Scale 62 permanently discontinue Vectibix 62 BENICAR 62 hsCRP levels 62 CIN3 62 serum triglyceride levels 62 intravaginal ejaculatory latency 62 x ULN 62 HAM D 62 hepatic enzymes 62 statistically significant p = 62 abacavir lamivudine 62 RAPTIVA 62 C Reactive Protein 62 fasting glucose levels 62 urate lowering therapy 62 Status Scale EDSS 62 tissue oxygenation 62 Visual Analog 62 CFQ R 62 Albuminuria 62 T2 lesion volume 62 atorvastatin #mg 62 trough FEV1 62 thyroglobulin 62 infliximab monotherapy 62 Teriflunomide 62 lipoprotein Lp 62 myeloperoxidase 62 paricalcitol 62 rhinoconjunctivitis 61 IU mL 61 nonvertebral fractures 61 INVEGA ® 61 hyperalgesia 61 myocardial necrosis 61 serum uric acid 61 Fasting plasma glucose 61 cTnT 61 Welchol 61 ropivacaine 61 Sustained virologic response 61 dalteparin 61 secondary endpoint 61 urinary calcium excretion 61 systemic corticosteroid 61 flow mediated dilation 61 arterial thromboembolic events 61 achieved sustained virological 61 MMSE scores 61 cerebral oxygen saturation 61 Engerix B 61 log# reduction 61 HRQL 61 TMP SMX 61 macrovascular events 61 unadjusted Purchase 61 sensitivity specificity 61 undetectable viral 61 transcranial Doppler ultrasound 61 ankle brachial 61 3mg/kg 61 placebo fluoxetine 61 mEq L 61 Adalimumab 61 ANCOVA 61 zonisamide SR 61 placebo p 61 serum homocysteine 61 ‰ ¥ 61 pulmonary arterial 61 ALT flares 61 resected pancreatic cancer 61 TNFalpha 61 achieved CCyR 61 overt nephropathy 61 non menstrual pelvic 61 HbA 1C 61 FACIT Fatigue 61 BPRS PSS 61 clinically meaningful improvements 61 mm Hg diastolic 61 interrater reliability 61 Ki# 61 fraction LVEF 61 etanercept 61 left ventricular systolic 61 apolipoprotein B 61 Endothelial dysfunction 61 HER2 overexpression 61 iPTH 61 insulin detemir 61 Histologic 61 exploratory endpoints 61 baseline serum creatinine 61 recurrent VTE 61 dactylitis 61 gout flare 61 partial remissions 61 glycosylated hemoglobin 61 retinal thickness 61 LEXIVA r 61 virologic 61 hemoglobin Hb 61 microalbuminuria 61 somatostatin analog 61 epoetin alpha 61 serum clusterin levels 61 pruritus itching 61 % CI #.#-#.# [003] 61 affective psychosis 61 eplerenone 61 T2DM 61 Postoperative complications 61 isoprostane 61 IU ml 61 lispro 61 flutamide 61 adjunctive ABILIFY 61 A1C levels 61 neurologic progression 61 EQ 5D 61 nmol l 61 Pegasys ® 61 urinary cortisol 61 serum sodium 61 Rate ORR 61 CYP#A# substrate 61 postop 61 X ULN 61 â ‰ ¥ 61 Hb A1c 61 salmeterol fluticasone 61 mL/min/#.# m2 61 rosuvastatin #mg 61 endometrial thickness 61 Solid Tumors 61 hypoglycemic events 61 peginterferon alfa 61 COPD exacerbation 61 paraprotein 61 Pemetrexed 61 nadolol 61 β blocker 61 LVEF 61 MMSE 61 dyssynchrony 61 plus dexamethasone 61 peak VO2 61 biopsy Gleason 61 #.#/#.# mm Hg [003] 61 Febrile neutropenia 61 adenotonsillectomy 61 peginterferon alfa 2a 61 Postoperatively 61 PANSS scores 61 thyrotropin levels 61 placebo p = 61 femoral neck BMD 61 univariate 61 histological subtype 61 paresthesias 61 TLUS 61 intravascular hemolysis 61 N telopeptide 61 divalproex sodium 61 death reinfarction 61 TAXUS p value 61 concomitant medications 61 Clinician Administered PTSD 61 Alanine 61 microvessel density 61 tapentadol IR 61 Serious adverse reactions 61 logistic regression analyzes 61 lipid parameters 61 seropositivity 61 irbesartan 61 genotypic resistance 61 mg BID 61 CP CPPS 61 NovoLog ® Mix 61 imipenem 61 neostigmine 61 neurocognitive function 61 Lupuzor ™ 61 NNT = 61 Cholinesterase Inhibitors 61 AMEX Broker Dealer 61 inflammatory biomarkers 61 Erectile Function 61 total cholesterol triglycerides 61 elevated LDH 61 NATRECOR R 61 prespecified secondary 61 Coronary artery calcium 61 cerebrovascular events 61 Hamilton Rating Scale 61 mean baseline A1C 61 CANCIDAS 61 Key secondary endpoints 61 lymphopenia 61 aldosterone antagonist 61 unfractionated heparin UFH 61 meta regression 61 Tasigna prolongs 61 blood Phe 61 IOP lowering 61 Decitabine 61 lipid lowering agents 61 ug dose 61 oxcarbazepine 61 ABC/3TC 61 p = #.# [003] 61 μg kg 61 splenectomized patients 61 AUA BPH Symptom Score 61 viral titers 61 Kaplan Meier method 61 hypopneas 61 Microalbuminuria 61 mcg Albuferon 61 FOLPI 61 + PH# 61 transaminase levels 61 hypokalemia 61 LV dysfunction 60 clinicopathological features 60 euthymic patients 60 mmHg systolic 60 serum concentrations 60 laboratory abnormalities 60 -#.# ± [002] 60 PegIFN RBV 60 PsA 60 metabolic parameters 60 logistic regression analysis 60 Major Adverse Cardiac 60 bivalirudin monotherapy 60 alemtuzumab treated 60 serum glucose 60 Hamilton Anxiety Scale 60 glycosylated hemoglobin levels 60 MACCE 60 urine NGAL 60 CSBMs 60 interquartile range 60 Risk Stratification 60 Kaplan Meier survival 60 sputum eosinophils 60 System IPSS 60 COPAXONE R 60 biochemical recurrence 60 Hematologic 60 elevated transaminases 60 hematologic toxicity 60 TPV r 60 Timed Walk 60 plasma homocysteine 60 adalimumab 60 sweat chloride 60 P = .# 60 hepatic enzyme 60 subtrochanteric 60 FluCAM 60 Cystatin C 60 serum PTH 60 aminotransferase elevations greater 60 angiotensin converting enzyme inhibitors 60 serum ferritin 60 serum CRP 60 unpaired t 60 Symptom Score 60 microalbumin test 60 complete Early Virological 60 clomipramine 60 CK # plasma concentrations 60 FOLFOX4 60 HADS 60 hemagglutination inhibition 60 nausea photophobia 60 Serum creatinine 60 sargramostim 60 invasive aspergillosis 60 thrombocytopenic 60 T2 lesions 60 lowest tertile 60 recurrent glioblastoma multiforme 60 severe neutropenia 60 SCIg 60 mcg mL 60 ancrod 60 IgG antibody 60 recurrent DVT 60 intraocular pressure IOP 60 reduce serum phosphate 60 ALSFRS R 60 urinary calcium 60 tPSA 60 ritonavir boosted 60 infarct size 60 FDG uptake 60 prednisone prednisolone 60 Cronbach alpha 60 mineral density 60 recurrent genital herpes 60 tertiles 60 5-FU/LV 60 experienced virologic failure 60 urinary albumin excretion 60 Prehypertension 60 receiving APTIVUS r 60 weekly CSBMs 60 treat NNT 60 mcg albinterferon alfa 2b 60 pegylated interferon alfa 60 RAPAFLO R 60 statistical significance p 60 abdominal adiposity 60 UACR 60 PERMP 60 procalcitonin 60 candesartan cilexetil 60 tacrolimus ointment 60 Betaferon R 60 S. aureus isolates 60 diabetes mellitus DM 60 airway hyperresponsiveness 60 #OHD levels 60 mcg kg 60 Thrombocytopenia 60 oral antidiabetic medication 60 CD4 CD8 60 Symptom Severity 60 ZOLINZA 60 systolic dysfunction 60 teriflunomide 60 q#h 60 hemorrhagic complications 60 prednisone prednisolone plus 60 Wechsler Adult 60 dermatologic toxicities 60 metastatic malignant 60 alicaforsen enema 60 Physical Component 60 pg mL 60 Main Outcome Measures 60 LV ejection fraction 60 ribavirin therapy 60 EDSS 60 Negative Symptoms 60 viral kinetics 60 elevated creatinine 60 glulisine 60 hyperphenylalaninemia HPA due 60 corrected QT interval 60 mycophenolate mofetil 60 oral allopurinol 60 Scale Cognitive Subscale 60 BYSTOLIC 60 #mg BID [001] 60 SPRYCEL ® 60 thromboembolic 60 transaminase 60 pretreatment serum 60 plus MTX 60 QTc intervals 60 Hycamtin ® 60 R# #mg BID 60 variance ANOVA 60 cells mcL 60 sulfasalazine 60 ALVESCO 60 serum ALT 60 mg eq 60 FDA defined valvulopathy 60 PEGylated anti 60 RESIST studies 60 oxygen desaturation 60 multiple logistic regression 60 rFSH 60 pimecrolimus cream 60 Xelox 60 events MACE 60 creatine kinase MB 60 Renal dysfunction 60 tumor histology 60 F FDG PET 60 Ashworth Scale 60 subclinical atherosclerosis 60 MELD scores 60 Naive Patients 60 PRADAXA #mg 60 aspirin clopidogrel 60 CRQ 60 Lagging Indicators 60 -5 -6 60 achieved sustained virologic 60 IRLS 60 autonomic dysfunction 60 Erythropoietic therapies may 60 remission CR 60 spontaneous bacterial peritonitis 60 Mania Rating Scale 60 prolonged QT interval 60 Abnormal Involuntary Movement 60 serum creatinine 60 elevated serum creatinine 60 DOXIL 60 adefovir treated 60 symptomatic intracranial hemorrhage 60 preoperative chemotherapy 60 statistically significant p 60 glycaemia 60 tocilizumab 60 vasopressor 60 eszopiclone 60 oral antidiabetic drugs 60 concentration Cmax 60 bezafibrate 60 fasting triglycerides 60 Comorbidity 60 CPAP adherence 60 severe renal impairment 60 #μg [001] 60 μmol l 60 electrophysiologic 60 #mmHg [001] 60 autoantibody levels 60 KRAS mutant tumors 60 PSA kinetics 60 lymphocytosis 60 AGILECT R 60 atherogenic dyslipidemia 60 interferon ribavirin 60 advanced adenomas 60 Cardiotoxicity 60 sd = 60 seroprotection 60 hepatic cirrhosis 60 nonvertebral fracture 60 antidiabetic medication 60 mL sec 60 Demonstrate Significant 60 primary aldosteronism 60 REMINYL ® 60 bioavailable testosterone 60 nonfatal myocardial infarction MI 60 periprocedural MI 60 SBM frequency 60 carotid intima media 60 histologic subtype 60 microalbumin 60 serum transaminases 60 dyslipidaemia 60 graft dysfunction 60 HIV HCV coinfected 60 clinically evaluable patients 60 Subgroup analysis 60 endometrial hyperplasia 60 Baseline characteristics 59 artery stenosis 59 clinicopathological 59 depressive symptomatology 59 vWF 59 acromegalic patients 59 pentoxifylline 59 unstable angina pectoris 59 MDRD 59 Median PFS 59 Pred Forte 59 patients evaluable 59 vitreous haze 59 logistic regression model 59 CIN2 + 59 LS BMD 59 symptomatic intracranial 59 patients undergoing CABG 59 unresectable HCC 59 hemoglobin A1C 59 nodular partial response 59 Main Outcome Measure 59 urate levels 59 D dimer 59 nonobstructive CAD 59 #mg doses [002] 59 univariate analyzes 59 pT3 59 dosing cohort 59 Univariate 59 ruboxistaurin 59 XIENCE V demonstrated 59 SLE Responder Index 59 anaphylactic reactions bronchospasm 59 exhaled nitric oxide 59 hypomagnesemia 59 CHD CVD 59 hemodynamic variables 59 cTnI 59 variceal bleeding 59 FEV1 59 primary efficacy endpoint 59 doxorubicin cyclophosphamide 59 CORE OM 59 Neuropsychiatric Inventory